These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28044059)

  • 1. The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder.
    Dubey N; Hoffman JF; Schuebel K; Yuan Q; Martinez PE; Nieman LK; Rubinow DR; Schmidt PJ; Goldman D
    Mol Psychiatry; 2017 Aug; 22(8):1172-1184. PubMed ID: 28044059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subgenual cingulate resting regional cerebral blood flow in premenstrual dysphoric disorder: differential regulation by ovarian steroids and preliminary evidence for an association with expression of ESC/E(Z) complex genes.
    Wei SM; Baller EB; Martinez PE; Goff AC; Li HJ; Kohn PD; Kippenhan JS; Soldin SJ; Rubinow DR; Goldman D; Schmidt PJ; Berman KF
    Transl Psychiatry; 2021 Apr; 11(1):206. PubMed ID: 33833224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback.
    Nguyen TV; Reuter JM; Gaikwad NW; Rotroff DM; Kucera HR; Motsinger-Reif A; Smith CP; Nieman LK; Rubinow DR; Kaddurah-Daouk R; Schmidt PJ
    Transl Psychiatry; 2017 Aug; 7(8):e1193. PubMed ID: 28786978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic intersection of BDNF Val66Met genotype with premenstrual dysphoric disorder transcriptome in a cross-species model of estradiol add-back.
    Marrocco J; Einhorn NR; Petty GH; Li H; Dubey N; Hoffman J; Berman KF; Goldman D; Lee FS; Schmidt PJ; McEwen BS
    Mol Psychiatry; 2020 Mar; 25(3):572-583. PubMed ID: 30356121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered estradiol-dependent cellular Ca
    Li HJ; Goff A; Rudzinskas SA; Jung Y; Dubey N; Hoffman J; Hipolito D; Mazzu M; Rubinow DR; Schmidt PJ; Goldman D
    Mol Psychiatry; 2021 Nov; 26(11):6963-6974. PubMed ID: 34035477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.
    Schmidt PJ; Martinez PE; Nieman LK; Koziol DE; Thompson KD; Schenkel L; Wakim PG; Rubinow DR
    Am J Psychiatry; 2017 Oct; 174(10):980-989. PubMed ID: 28427285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.
    Bixo M; Johansson M; Timby E; Michalski L; Bäckström T
    J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 29072794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen levels, emotion regulation, and emotional symptoms of women with premenstrual dysphoric disorder: The moderating effect of estrogen receptor 1α polymorphism.
    Yen JY; Wang PW; Su CH; Liu TL; Long CY; Ko CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():216-223. PubMed ID: 29146473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premenstrual dysphoric disorder is associated with the longer length from clitoris to urethra.
    Li Z; Xu MJ; Jin Y; Zhu BG
    BMC Womens Health; 2021 Jul; 21(1):266. PubMed ID: 34225734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress, mood, and cortisol during daily life in women with Premenstrual Dysphoric Disorder (PMDD).
    Beddig T; Reinhard I; Kuehner C
    Psychoneuroendocrinology; 2019 Nov; 109():104372. PubMed ID: 31357135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen, progesterone, cortisol, brain-derived neurotrophic factor, and vascular endothelial growth factor during the luteal phase of the menstrual cycle in women with premenstrual dysphoric disorder.
    Ko CH; Wong TH; Suen JL; Lin PC; Long CY; Yen JY
    J Psychiatr Res; 2024 Jan; 169():307-317. PubMed ID: 38070471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotrophic hormone and reinforcement sensitivity systems in women with premenstrual dysphoric disorder.
    Ko CH; Long CY; Yen CF; Chen CS; Wang PW; Yen JY
    Psychiatry Clin Neurosci; 2014 Nov; 68(11):785-94. PubMed ID: 24735107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.
    Yen JY; Lin HC; Lin PC; Liu TL; Long CY; Ko CH
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31703451
    [No Abstract]   [Full Text] [Related]  

  • 14. What's Stopping Us? Using GnRH Analogs With Stable Hormone Addback in Treatment-Resistant Premenstrual Dysphoric Disorder: Practical Guidelines and Risk-Benefit Analysis for Long-term Therapy.
    Wagner-Schuman M; Kania A; Barone JC; Ross JM; Mulvihill A; Eisenlohr-Moul TA
    J Clin Psychiatry; 2023 Jun; 84(4):. PubMed ID: 37341478
    [No Abstract]   [Full Text] [Related]  

  • 15. The late-luteal leptin level, caloric intake and eating behaviors among women with premenstrual dysphoric disorder.
    Ko CH; Yen CF; Long CY; Kuo YT; Chen CS; Yen JY
    Psychoneuroendocrinology; 2015 Jun; 56():52-61. PubMed ID: 25800149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuli.
    Gingnell M; Bannbers E; Wikström J; Fredrikson M; Sundström-Poromaa I
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1474-83. PubMed ID: 24001875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.
    Timby E; Bäckström T; Nyberg S; Stenlund H; Wihlbäck AN; Bixo M
    Psychopharmacology (Berl); 2016 Jun; 233(11):2109-2117. PubMed ID: 26960697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for reproductive steroids in the etiology and treatment of affective disorders?
    Rubinow DR; Schmidt PJ
    Dialogues Clin Neurosci; 2018 Sep; 20(3):187-196. PubMed ID: 30581288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot Data on the Feasibility And Clinical Outcomes of a Nomegestrol Acetate Oral Contraceptive Pill in Women With Premenstrual Dysphoric Disorder.
    Robertson E; Thew C; Thomas N; Karimi L; Kulkarni J
    Front Endocrinol (Lausanne); 2021; 12():704488. PubMed ID: 34630323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of premenstrual dysphoric disorder and menstrual cycle phase on brain activity during response inhibition.
    Bannbers E; Gingnell M; Engman J; Morell A; Comasco E; Kask K; Garavan H; Wikström J; Sundström Poromaa I
    J Affect Disord; 2012 Dec; 142(1-3):347-50. PubMed ID: 22840469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.